[USE OF METHIMAZOLE AS A PRE-TREAMENT DRUG IN I-131 THERAPY OF SEVERE THYROTOXICOSIS WITH EXTREMELY HIGH IODINE METABOLISM RATE].
D013956:Antithyroid Agents; D006801:Humans; D006980:Hyperthyroidism; D007455:Iodine; D007456:Iodine Isotopes / Q000627:therapeutic use*; D008713:Methimazole; D013960:Thyroid Function Tests; D013971:Thyrotoxicosis
D013956:Antithyroid Agents; D007456:Iodine Isotopes; D008713:Methimazole; D007455:Iodine
HYPERTHYROIDISM; IODINE ISOTOPES, THERAPEUTIC; THYROID ANTAGONISTS; THYROID GLAND FUNCTION TESTS
METHIMAZOLVERABREICHUNG ALS VORBEREITUNG FUER DIE J-131-THERAPIE SCHWERER THYREOTOXIKOSEN MIT EXTREM BESCHLEUNIGTEM JODUMSATZ.